Why Would Caregivers Not Want to Treat Their Relative's Alzheimer's Disease?

Objectives: To determine family caregivers' willingness to use Alzheimer's disease (AD)‐slowing medicines and to examine the relationships between this willingness, dementia severity, and caregiver characteristics.

[1]  D. Hosmer,et al.  Model‐Building Strategies and Methods for Logistic Regression , 2005 .

[2]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[3]  Bryan D. James,et al.  Relationship between Alzheimer's Disease Severity and Patient Participation in Decisions about Their Medical Care , 2002, Journal of geriatric psychiatry and neurology.

[4]  Dirk Deleu,et al.  A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. , 2001, Neurology.

[5]  J. Karlawish,et al.  The Relationship Between Caregivers' Global Ratings of Alzheimer's Disease Patients' Quality of Life, Disease Severity, and the Caregiving Experience , 2001, Journal of the American Geriatrics Society.

[6]  T Ostbye,et al.  A reevaluation of the duration of survival after the onset of dementia. , 2001, The New England journal of medicine.

[7]  D. Asch,et al.  Caregivers’ preferences for the treatment of patients with Alzheimer’s disease , 2000, Neurology.

[8]  P J Neumann,et al.  Alzheimer's disease care: costs and potential savings. , 1998, Health affairs.

[9]  E. Mandelkow,et al.  Tau in Alzheimer's disease. , 1998, Trends in cell biology.

[10]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[11]  P. Whitehouse,et al.  Emerging Antidementia Drugs: A Preliminary Ethical View , 1998, Journal of the American Geriatrics Society.

[12]  G. Sachs.  Dementia and the Goals of Care , 1998, Journal of the American Geriatrics Society.

[13]  P Woodbury,et al.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.

[14]  J. Lynn,et al.  Is economic hardship on the families of the seriously ill associated with patient and surrogate care preferences? SUPPORT Investigators. , 1996, Archives of internal medicine.

[15]  C. Clark,et al.  Performance of the Dementia Severity Rating Scale: A Caregiver Questionnaire for Rating Severity in Alzheimer Disease , 1996, Alzheimer disease and associated disorders.

[16]  Alison T. O'Brien,et al.  Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. , 1995, The Gerontologist.

[17]  H. Young,et al.  The screen for caregiver burden. , 1991, The Gerontologist.

[18]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[19]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[20]  A. Strauss,et al.  Basics of Qualitative Research (3rd ed.): Techniques and Procedures for Developing Grounded Theory , 2008 .

[21]  H. Tuokko,et al.  Predicting caregiver burden and depression in Alzheimer's disease. , 2000, The journals of gerontology. Series B, Psychological sciences and social sciences.

[22]  L. Gibbons,et al.  Quality of life in Alzheimer's disease: Patient and caregiver reports. , 1999 .

[23]  L. Gibbons,et al.  Quality of life in Alzheimer's Disease , 1999 .

[24]  A. Burns.  Clinical diagnosis of Alzheimer's disease , 1991 .

[25]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.